CDP Funded Phased Innovation and Phased Application Awards in FY2001
- R21 and R33 Grants Awarded by CDP in Response to PAR-99-100, Innovative Technologies for the Molecular Analysis of Cancer: Phased Innovation Award (R21/R33)
- R21 Grant Awarded by CDP in Response to PAR-99-102, Applications of Innovative Technologies for the Molecular Analysis of Cancer: Phased Technology Application Award (R21/R33)
R21 and R33 Grants Awarded by CDP in Response to PAR-99-100, Innovative Technologies for the Molecular Analysis of Cancer: Phased Innovation Award (R21/R33)
(PAR-99-100 has been superseded by PAR-01-104, Innovative Technologies for the Molecular Analysis of Cancer: Phases Innovation Award)
Faris, Gregory W, PhD
Upconverting Chelates for Cancer Detection and Diagnosis
SRI International, Menlo Park, CA
Farkas, Daniel L, PhD
Cancer Molecule Analysis by AOTF Multispectral Imaging
University of Pittsburgh at Pittsburgh, Pittsburgh, PA
Fresco, Jacques R, PhD
Fluorescent TISH Probes for Cancer-relevant Sequences
Princeton University, Princeton, NJ
Guo, Baochuan, PhD
MALDI-TOF Technology for Molecular Analysis of Cancer
Cleveland State University, Cleveland, OH
Lieber, Charles M, PhD
Carbon Nanotube Probes for Direct DNA Sequence Analysis
Harvard University, Cambridge, MA
Sikic, Branimir I, MD
Gene Expression Profiling of Unknown Primary Cancers
Stanford University, Stanford, CA
Yamamoto, Fumiichiro, PhD
New Technology to Detect Genome-wide DNA Methylation Changes
The Burnham Institute, La Jolla, CA
See More:
All NCI awards in response to PAR-99-100 in FY 2001.
R21 Grant Awarded by CDP in Response to PAR-99-102, Applications of Innovative Technologies for the Molecular Analysis of Cancer: Phased Technology Application Award (R21/R33)
(PAR-99-102 has been superseded by PAR-01-106, Applications of Innovative Technologies for the Molecular Analysis of Caoncer: Phased Innovation Award)
Parkos, Charles A, MD, PhD
Phage Display and Prostate Neoplasia Progression
Emory University, Atlanta, GA
See More:
All NCI awards in response to PAR-99-102 and PAR-99-103 in FY 2001.
